Regulation of Stemness by NR1D2 in Colorectal Cancer.
Sandra Alonso-García, Paula Sánchez-Uceta, Sara Moreno-SanJuan, Jorge Casado, Jose D Puentes-Pardo, Huda Khaldy, David Lopez-Pérez, María Sol Zurita-Saavedra, Cristina González-Puga, Angel Carazo and 1 more
Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Sandra Alonso-GarcíaUnidad de Gestión Clínica de Cirugía, Hospital Clínico Universitario San Cecilio, 18012 Granada, Spain.
Paula Sánchez-UcetaInstituto de Investigación Biosanitaria de Granada(ibs.GRANADA), 18012 Granada, Spain.
Sara Moreno-SanJuanServicio de Microscopía y Citometría, Instituto de Investigación Biosanitaria de Granada(ibs.GRANADA), 18012 Granada, Spain.
Jorge CasadoInstituto de Investigación Biosanitaria de Granada(ibs.GRANADA), 18012 Granada, Spain.
Jose D Puentes-PardoInstituto de Investigación Biosanitaria de Granada(ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0002-6417-6019
Huda KhaldyServicio de Biología Fundamental, Centro de Instrumentación Científica, Universidad de Granada, 18071 Granada, Spain.
David Lopez-PérezLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-6443-6773
María Sol Zurita-SaavedraUnidad de Gestión Clínica de Cirugía, Hospital Clínico Universitario San Cecilio, 18012 Granada, Spain.
Cristina González-PugaUnidad de Gestión Clínica de Cirugía, Hospital Clínico Universitario San Cecilio, 18012 Granada, Spain.
Angel CarazoInstituto de Investigación Biosanitaria de Granada(ibs.GRANADA), 18012 Granada, Spain.
Josefa LeónInstituto de Investigación Biosanitaria de Granada(ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0002-0543-4823
Funding
Consejería de Salud, Junta de Andalucia PI-067/2013Instituto de Salud Carlos III P21/01378
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
cancer stem cellscircadian clockcolorectal cancerNR1D2p53
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Regulation of Stemness by NR1D2 in Colorectal Cancer. · full record | OpenQuestion